Prognostic Value of CD109+ Circulating Endothelial Cells in Recurrent Glioblastomas Treated with Bevacizumab and Irinotecan

Lucia Cuppini; Angelica Calleri; Maria Grazia Bruzzone; Elena Prodi; Elena Anghileri; Serena Pellegatta; Patrizia Mancuso; Paola Porrati; Anna Luisa Di Stefano; Mauro Ceroni; Francesco Bertolini; Gaetano Finocchiaro; Marica Eoli

doi:10.1371/journal.pone.0074345

Loading metrics

Open Access

Peer-reviewed

Research Article

Prognostic Value of CD109+ Circulating Endothelial Cells in Recurrent Glioblastomas Treated with Bevacizumab and Irinotecan

Lucia Cuppini,

Affiliation Department of Neuro-Oncology Unit, Fondazione IRCCS Istituto Neurologico C, Besta, Milan, Italy
⨯
Angelica Calleri,

Affiliation Department of Hematology-Oncology, European Institute of Oncology, Milan, Italy
⨯
Maria Grazia Bruzzone,

Affiliation Department of Neuro-Radiology, Fondazione IRCCS Istituto Neurologico C, Besta, Milan, Italy
⨯
Elena Prodi,

Affiliation Department of Neuro-Radiology, Fondazione IRCCS Istituto Neurologico C, Besta, Milan, Italy
⨯
Elena Anghileri,

Affiliation Department of Neuro-Oncology Unit, Fondazione IRCCS Istituto Neurologico C, Besta, Milan, Italy
⨯
Serena Pellegatta,

Affiliation Department of Neuro-Oncology Unit, Fondazione IRCCS Istituto Neurologico C, Besta, Milan, Italy
⨯
Patrizia Mancuso,

Affiliation Department of Hematology-Oncology, European Institute of Oncology, Milan, Italy
⨯
Paola Porrati,

Affiliation Department of Neuro-Oncology Unit, Fondazione IRCCS Istituto Neurologico C, Besta, Milan, Italy
⨯
Anna Luisa Di Stefano,

Affiliations Department of Neuro-Oncology Unit, Fondazione IRCCS Istituto Neurologico C, Besta, Milan, Italy, Department of Neurology, Fondazione IRCCS Istituto Neurologico Nazionale C. Mondino, Pavia, Italy
⨯
Mauro Ceroni,

Affiliation Department of Neurology, Fondazione IRCCS Istituto Neurologico Nazionale C. Mondino, Pavia, Italy
⨯
Francesco Bertolini,

Affiliation Department of Hematology-Oncology, European Institute of Oncology, Milan, Italy
⨯
Gaetano Finocchiaro ,

* E-mail: gaetano.finocchiaro@gmail.com

Affiliation Department of Neuro-Oncology Unit, Fondazione IRCCS Istituto Neurologico C, Besta, Milan, Italy
⨯
Marica Eoli

Affiliation Department of Neuro-Oncology Unit, Fondazione IRCCS Istituto Neurologico C, Besta, Milan, Italy
⨯

Prognostic Value of CD109+ Circulating Endothelial Cells in Recurrent Glioblastomas Treated with Bevacizumab and Irinotecan

Lucia Cuppini,
Angelica Calleri,
Maria Grazia Bruzzone,
Elena Prodi,
Elena Anghileri,
Serena Pellegatta,
Patrizia Mancuso,
Paola Porrati,
Anna Luisa Di Stefano,
Mauro Ceroni

Published: September 12, 2013
https://doi.org/10.1371/journal.pone.0074345

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Cancers and neoplasms
Is the Subject Area "Cancers and neoplasms" applicable to this article?

Thanks for your feedback.
Endothelial cells
Is the Subject Area "Endothelial cells" applicable to this article?

Thanks for your feedback.
Magnetic resonance imaging
Is the Subject Area "Magnetic resonance imaging" applicable to this article?

Thanks for your feedback.
Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.
Glioblastoma multiforme
Is the Subject Area "Glioblastoma multiforme" applicable to this article?

Thanks for your feedback.
Breast cancer
Is the Subject Area "Breast cancer" applicable to this article?

Thanks for your feedback.
Malignant tumors
Is the Subject Area "Malignant tumors" applicable to this article?

Thanks for your feedback.